Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Torrent's Rosuvastatin vs Crestor in Healthy Fed Subjects
NCT02962323Phase 1Completed
- Sponsor
- Torrent Pharmaceuticals Limited
- Start
- Nov 2009
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin in hypercholesterolemia (2 arms), sponsored by Torrent Pharmaceuticals Limited. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve. Started Nov 2009; status: completed.
02
Drugs
rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02962323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02962323.